Gilead Sciences Inc (GILD)

81.39
-2.61(-3.11%)
After Hours
85.15
+3.76(+4.62%)
- Real-time Data
  • Volume:
    10,713,212
  • Day's Range:
    80.48 - 82.50
  • 52 wk Range:
    57.17 - 89.74

GILD Overview

Prev. Close
84
Day's Range
80.48-82.5
Revenue
19.89B
Open
82.36
52 wk Range
57.17-89.74
EPS
2.66
Volume
10,713,212
Market Cap
102.08B
Dividend (Yield)
2.92
(3.49%)
Average Vol. (3m)
7,290,244
P/E Ratio
30.36
Beta
0.468
1-Year Change
23.66%
Shares Outstanding
1,254,243,845
Next Earnings Date
May 04, 2023
What is your sentiment on Gilead?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
14400

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.

Read More

Analyst Price Target

Average86.22 (+5.93% Upside)
High111.00
Low63.00
Price81.39
No. of Analysts23
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellBuy
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Buy
SummaryStrong BuyNeutralStrong SellStrong SellStrong Buy
  • Who cares about dividends when this stock shows weakness year after year, is not a good deal to get 5% per year if you are constantly worried about this stock sinks under 2013 lows
    0
    • Are you a coinbase client? 😉
      0
  • it sucks...
    0
    • invest stock gild.us at basel markets to take home divedends
      0
      • Projected earnings beat but I'd bet it doesn't move the needle -
        0
        • Another 15 or so shares into this.
          1
          • I've held this since 2014 or so. COULD have picked NVDA for approx 15 - 20 😒Did I pick the winner eh?
            2
            • Amazing how GILD managed to disappoint on EVERY earnings report.
              4
              • Yes, even a beat is disapointing -
                0
            • What's happening?!
              1
              • Everyone in market is here to make money. Gilead saved my wife's life. I will donate all my money for this one organization who is working to safe our life ...
                1
                • I a, donating money for good cause, buying Gilead
                  0